While the use of telehealth and Remote Patient Monitoring skyrocketed during COVID-19, what does it mean for the healthcare industry as the pandemic is showing signs of abating? InfoBionic CEO Stuart Long explains how RPM technology ensures telehealth is here to stay.
WALTHAM, Mass., June 14, 2021 /PRNewswire-PRWeb/ -- It's no secret that the use of telehealth technologies rose dramatically with the onset of the COVID-19 pandemic. In efforts to keep patients safe, doctors across the country turned to remote patient monitoring (RPM) to evaluate and monitor patients while keeping them at home. Even before the pandemic, nine out of ten healthcare providers indicated they were evaluating or had already invested in remote patient monitoring technologies to better assist their patients.(1) And now, as America seems to be rounding out of the pandemic, telehealth and RPM are here to stay—so believes the American Medical Association.(2)
"COVID-19 strained our already overburdened healthcare system to the max, and many doctors chose to go with remote patient monitoring to help alleviate that strain and keep patients safe from COVID-19. But not all RPM devices are created equal, and doctors need to feel confident that their choice of technology provides a truly comprehensive picture of a patient's health," explains Stuart Long, CEO of InfoBionic, a leading digital health technology company.
Remote patient monitoring uses innovative technological tools to gather and track patient data outside standard healthcare settings.(3) Cardiology was one of the first medical specialties to incorporate RPM into standard practice.(4) Some studies already show that patients using RPM showed a 50% drop in mortality from arrhythmias and congestive heart failure compared to those receiving standard, in-person follow-up.(4)
How does it work?
InfoBionic introduced the MoMe® Kardia as the first mobile cardiac telemetry (MCT) technology that provides near real-time on-demand full disclosure of ECG data 24/7. Using a one-piece monitor, MoMe® continuously records telemetry data, uploading it to a cloud-based platform that clinicians may access anytime, anywhere. Automated reports show onset, offset, and other supplementary data that any cardiologist may use to verify or rule out cardiac events. MoMe® presents this information in a HIPAA-compliant portal that helps to protect sensitive patient health information.
In addition to benefitting the patient, cardiac RPM devices help the clinician as well.
By remotely transitioning the monitor between Holter, Event, and MCT during monitoring periods (depending on patient need), RPM streamlines office and hospital visits.(5)
Eliminates the need for intermediaries in patient enrollments, IDTF data delays and helps to gain control of patient compliance.(5)
By recording every single heartbeat and providing on-demand access to 100% of acquired heartbeats, the data can enhance the clinician's ability to detect—and make timely diagnoses of atrial fibrillation, tachycardia, and other arrhythmias.(5)
The physician can facilitate decision-making with control of all reporting and get all the data needed to optimize diagnosis accuracy.(5)
Remote cardiac monitoring has become part of the standard of care for cardiac patients, especially those with implantable cardiac devices.(6) Easy access to real-time telemetry data allows cardiologists to decide whether symptoms represent true medical emergencies, essentially creating a "hospital without walls". Additionally, one-fourth of healthcare organizations report that RPM reduces emergency department visits and hospital readmissions; 38% of organizations say the technology results in fewer inpatient admissions for problems like heart disease or chronic obstructive pulmonary disease.(7)
The Future of RPM
Current generations of remote patient monitoring technology cannot monitor all vitals—oxygen level, ECG, blood pressure, blood glucose, etc.—at the same time and/or in the same device. However, biotech companies are working to develop a kind of "tricorder" technology, similar to that seen in "Star Trek". Long anticipates that this kind of innovative technology will become more precise, more accepted, and simply a reality—hopefully, in the not too distant future.
In fact, in 2012, a contest was announced to develop a medical tricorder and win a $10 million prize. Three hundred teams competed and in 2017, 2 biotech companies were chosen to lead the project.(8) According to a Scientific American article, "The main aim of the two prizewinners is to integrate several technologies in one device. They haven't created an all-in-one handheld machine, but they do both represent significant steps forward."(9).
While the standard office visit is not yet a thing of the past, many believe that RPM technologies like MoMe® represent the future of healthcare. Doctors, explains Long, will probably use a hybrid model, combining in-person care with virtual visits for a more comprehensive and convenient approach to care. RPM technology will be key to differentiating true emergencies from non-emergent situations, which benefits both the patient and the healthcare system as a whole.
Long says, "As our technology advances, we hope that more providers will come to realize just how important full disclosure data is to making an accurate diagnosis and improving patient outcomes. We're already seeing the widespread adoption of these technologies, and we believe their use in healthcare will continue to expand."
InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices, and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks hindering faster, more effective diagnosis and decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic. Visit infobionic.com.
Tashnek, Daniel. 16 Remote Patient Monitoring Statistics Every Practice Should Know, 11 Aug. 2020, blog.prevounce.com/16-remote-patient-monitoring-statistics-every-practice-should-know.
Robeznieks, Andis; "Q&A: Telehealth here to stay, but doctors' key requirements remain"; 25 Feb 2021; AMA; ama-assn.org/practice-management/digital/qa-telehealth-here-stay-doctors-key-requirements-remain
"Everything You Need to Know About Remote Patient Monitoring." OrthoLive, 16 Sept. 2020, ortholive.com/blog/everything-you-need-to-know-about-remote-patient-monitoring/.
Tashnek, Daniel. "How Remote Patient Monitoring Is Changing the Practice of Cardiology." Practical Cardiology, 6 Nov. 2020, practicalcardiology.com/view/how-remote-patient-monitoring-is-changing-the-practice-of-cardiology.
Infobionic.com; "Get true telemetry data for new insights that drive better outcomes"; InfoBionic; infobionic.com/eps-cardiologists-afib-monitor/ | Accessed 10 June 2021.
Miller, Jennifer C., et al. "Home Monitoring of Cardiac Devices in the Era of COVID-19." Current Cardiology Reports, Springer US, 20 Nov. 2020, link.springer.com/article/10.1007/s11886-020-01431-w.
Bryant, Meg. "Remote Patient Monitoring Cuts Hospital Admissions, ER Visits, Report Finds." Healthcare Dive, 8 Oct. 2018, healthcaredive.com/news/remote-patient-monitoring-cuts-hospital-admissions-er-visits-report-finds/539073/.
Samuel, Leah; "With $10 million at stake, scientists compete to build a 'Star Trek'-style medical tricorder"; 21 Feb 2017; STAT; statnews.com/2017/02/21/x-prize-tricorder-medicine/
Moschou, Despina; "How Close Are We to a Real 'Star Trek'-Style Medical Tricorder?"; 16 June 2017; Scientific American; scientificamerican.com/article/how-close-are-we-to-a-real-star-trek-style-medical-tricorder/
Karla Jo Helms, JOTO PR Disruptors(TM), 727-777-4621, firstname.lastname@example.org
Daniel Mutter, JOTO PR Disruptors(TM), 727-777-4621, email@example.com